Zeist, Netherlands

Hendrik S Jansz


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hendrik S Jansz

Introduction

Hendrik S Jansz is a notable inventor based in Zeist, Netherlands. He has made significant contributions to the field of biochemistry, particularly in the development of oligopeptides and their applications in medicine. His work has implications for treating various health disorders, showcasing the intersection of science and innovation.

Latest Patents

Hendrik S Jansz holds a patent for "Oligopeptides and intermediates and processes for their manufacture." This patent describes peptides that include specific amino acid sequences capable of forming intra- or inter-molecular disulfide bridges. The invention also covers derivatives of these peptides, including those with amidated terminal carboxy groups and acylated terminal amino groups. Furthermore, it details the DNA sequences coding for these peptides, the microorganisms containing these sequences, and the processes for their manufacture. The patent emphasizes the pharmaceutical preparations that utilize these peptide-amides for treating coronary circulation disorders and bone metabolism disorders.

Career Highlights

Hendrik S Jansz has been associated with Ciba-Geigy Corporation, a company known for its advancements in pharmaceuticals and chemicals. His work at the corporation has allowed him to focus on innovative solutions in the field of biochemistry.

Collaborations

Throughout his career, Jansz has collaborated with esteemed colleagues such as Cornelis J Lips and Paul H Steenbergh. These collaborations have contributed to the advancement of research and development in their respective fields.

Conclusion

Hendrik S Jansz's contributions to the field of biochemistry through his patent on oligopeptides highlight the importance of innovation in medical science. His work continues to influence the development of treatments for critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…